 |
|
|
| |
Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112
|
| |
| |
Reported by Jules Levin
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, Vancouver, Canada BC
Samir K. Gupta1, Anton Pozniak2, Jose Arribas3, Frank A. Post4, Mark Bloch5, Joseph Gathe6, Paul Benson7, Joseph Custodio8, Michael Abram8, Xuelian Wei8, Andrew Cheng8, Scott McCallister8, Marshall W Fordyce8
1Indiana University School of Medicine, Indianapolis, IN, USA; 2Chelsea and Westminster Hospital NHS Foundation Trust, London, UK; 3Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; 4King's College Hospital NHS Foundation Trust, London, UK; 5Holdsworth House Medical Practice, Darlinghurst, NSW, AUS 6Therapeutic Concepts, Houston, TX, USA; 7Be Well Medical Center, Berkley, MI, USA; 8Gilead Sciences, Foster City, CA, USA
|
| |
|
|
|
|
|
